Sandoz Launches Pyzchiva Autoinjector, First Commercially Available In Europe For Ustekinumab Biosimilars
Pyzchiva first ustekinumab biosimilar in Europe commercially available in pre-filled pen (autoinjector), offering improved self-administration experience for better treatment adherence and quality of life [1-10] Autoinjector includes unique features to …